Pages that link to "Q47381459"
Jump to navigation
Jump to search
The following pages link to A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. (Q47381459):
Displaying 31 items.
- Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita (Q24250186) (← links)
- The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature (Q28067526) (← links)
- Evidence for the use of intravenous immunoglobulins--a review of the literature (Q33385332) (← links)
- Ocular cicatricial pemphigoid: manifestations and management (Q36168693) (← links)
- Clinical uses of intravenous immunoglobulin. (Q36264883) (← links)
- Intravenous immunoglobulin in eye involvement (Q36359703) (← links)
- Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology (Q36711702) (← links)
- Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. (Q36757383) (← links)
- Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders (Q36794149) (← links)
- Human immunoglobulins in intraocular inflammation (Q36958343) (← links)
- Treatment of pyoderma gangrenosum with intravenous immunoglobulin (Q36960643) (← links)
- The use of i.v. IG therapy in dermatology (Q36986054) (← links)
- Ocular mucous membrane pemphigoid: diagnosis and management strategies. (Q37264280) (← links)
- High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases (Q37532013) (← links)
- Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update (Q37933423) (← links)
- The Use of Intravenous Immunoglobulin in Autoimmune Bullous Diseases (Q37933780) (← links)
- Pemphigoid diseases (Q38067153) (← links)
- Urban legend series: mucous membrane pemphigoid (Q38169809) (← links)
- Chronic Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: The Role of Systemic Immunomodulatory Therapy (Q38766862) (← links)
- European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology. (Q38776260) (← links)
- Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management (Q38980040) (← links)
- The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on. (Q39096598) (← links)
- European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology (Q39608977) (← links)
- Treatment strategies in mucous membrane pemphigoid (Q41359384) (← links)
- Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid (Q43789787) (← links)
- Mucous membrane pemphigoid with ocular involvement. Part II: therapy (Q46661473) (← links)
- Mucous membrane pemphigoid (Q49833864) (← links)
- Ocular Mucous Membrane Pemphigoid: Current State of Pathophysiology, Diagnostics and Treatment (Q64230980) (← links)
- [Intravenous immunoglobulins: therapeutic indications] (Q81317771) (← links)
- [Indications for intravenous immunoglobulins] (Q83154740) (← links)
- Pentoxifylline (Anti-Tumor Necrosis Factor Drug): Effective Adjuvant Therapy in the Control of Ocular Cicatricial Pemphigoid (Q83328103) (← links)